{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:00:14Z","timestamp":1771844414131,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"313","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Morphologie"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.morpho.2012.08.001","type":"journal-article","created":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T05:00:59Z","timestamp":1348722059000},"page":"40-43","source":"Crossref","is-referenced-by-count":13,"title":["Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate"],"prefix":"10.1016","volume":"96","author":[{"given":"E.","family":"Hopp\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Laffitte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Chappard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Audran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.morpho.2012.08.001_bib0005","series-title":"Bisphosphonates in bone diseases. From the laboratory to the patient.","author":"Fleisch","year":"2000"},{"key":"10.1016\/j.morpho.2012.08.001_bib0010","first-page":"233","article-title":"Mechanisms of action of etidronate and other bisphosphonates","volume":"9","author":"Ebetino","year":"1998","journal-title":"Rev Contemp Pharmacother"},{"key":"10.1016\/j.morpho.2012.08.001_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jbmr.5650080211","article-title":"Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis","volume":"8","author":"Storm","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.morpho.2012.08.001_bib0020","first-page":"193","article-title":"Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5mg\/kg\/day)","author":"Alexandre","year":"1983","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.morpho.2012.08.001_bib0025","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(74)90347-X","article-title":"Diphosphonates in Paget's disease","volume":"1","author":"Russell","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.morpho.2012.08.001_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5414\/CN107207","article-title":"Is trans-iliac bone biopsy a painful procedure?","volume":"77","author":"Audran","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.morpho.2012.08.001_bib0035","first-page":"2183","article-title":"Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis","volume":"22","author":"Thomas","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.morpho.2012.08.001_bib0040","first-page":"150","article-title":"Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP)","author":"Mautalen","year":"1986","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.morpho.2012.08.001_bib0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(84)92272-4","article-title":"Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease","volume":"1","author":"Boyce","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.morpho.2012.08.001_bib0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jcem-44-1-96","article-title":"Diphosphonate therapy of paget's disease of bone","volume":"44","author":"Canfield","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.morpho.2012.08.001_bib0055","first-page":"34","article-title":"A new case of pseudosarcomatous osteolysis in a patient with Paget's disease treated with disodium etidronate","volume":"19","author":"Chapuis","year":"1990","journal-title":"Presse Med"},{"key":"10.1016\/j.morpho.2012.08.001_bib0060","first-page":"293","article-title":"Pseudotumoral osteolysis caused by diphosphonates","volume":"53","author":"Fedou","year":"1986","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.morpho.2012.08.001_bib0065","first-page":"115","article-title":"Diphosphonate treatment of Paget's disease","author":"Finerman","year":"1976","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.morpho.2012.08.001_bib0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/0248-8663(96)82694-4","article-title":"Pseudosarcomatous osteolysis of the femur in a patient with Paget's bone disease treated with long-term etidronate disodium: apropos of a new case","volume":"17","author":"Marin","year":"1996","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.morpho.2012.08.001_bib0075","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.1780231020","article-title":"The action of the main therapeutic regimes on Paget's disease of bone, with a note on the effects of vitamin D deficiency","volume":"23","author":"Nagant de Deuxchaisnes","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.morpho.2012.08.001_bib0080","first-page":"417","article-title":"Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate","volume":"51","author":"Pinel","year":"1984","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.morpho.2012.08.001_bib0085","first-page":"49","article-title":"Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)","volume":"51","author":"Rondier","year":"1984","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.morpho.2012.08.001_bib0090","first-page":"102","article-title":"Focal osteolysis as a complication of therapy for Paget's disease: case report","volume":"49","author":"Zander","year":"1998","journal-title":"Can Assoc Radiol J"},{"key":"10.1016\/j.morpho.2012.08.001_bib0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S8756-3282(96)00368-7","article-title":"Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone","volume":"20","author":"Devogelaer","year":"1997","journal-title":"Bone"}],"container-title":["Morphologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286011512000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286011512000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T08:51:50Z","timestamp":1542703910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286011512000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":19,"journal-issue":{"issue":"313","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1286011512000331"],"URL":"https:\/\/doi.org\/10.1016\/j.morpho.2012.08.001","relation":{},"ISSN":["1286-0115"],"issn-type":[{"value":"1286-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}